GeneDx Holdings WGS EBIT
Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's EBIT?
- GeneDx Holdings (WGS) reported EBIT of -$57.47M in Q1 2026.
- How has GeneDx Holdings's EBIT changed year-over-year?
- GeneDx Holdings's EBIT decreased by 1162.8% year-over-year, from -$4.55M to -$57.47M.
- What is the long-term trend for GeneDx Holdings's EBIT?
- Over 3 years (2021 to 2025), GeneDx Holdings's EBIT has grown at a -60.2% compound annual growth rate (CAGR), from -$207.17M to -$13.08M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.